Free Trial

Procter & Gamble (PG) Financials

Procter & Gamble logo
$157.49 -1.97 (-1.24%)
Closing price 09/10/2025 03:59 PM Eastern
Extended Trading
$157.51 +0.02 (+0.02%)
As of 09:25 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Annual Income Statements for Procter & Gamble

Annual Income Statements for Procter & Gamble

This table shows Procter & Gamble's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 6/30/2015 6/30/2016 6/30/2017 6/30/2018 6/30/2019 6/30/2020 6/30/2021 6/30/2022 6/30/2023 6/30/2024 6/30/2025
Net Income / (Loss) Attributable to Common Shareholders
7,036 10,508 15,326 9,750 3,897 13,027 14,306 14,742 14,653 14,879 15,974
Consolidated Net Income / (Loss)
7,144 10,604 15,411 9,861 3,966 13,103 14,352 14,793 14,738 14,974 16,065
Net Income / (Loss) Continuing Operations
8,287 10,027 10,194 9,861 3,966 13,103 14,352 14,793 14,738 14,974 16,065
Total Pre-Tax Income
11,012 13,369 13,257 13,326 6,069 15,834 17,615 17,995 18,353 18,761 20,167
Total Operating Income
11,049 13,441 13,766 13,363 5,487 15,706 17,986 17,813 18,134 18,545 20,451
Total Gross Profit
33,693 32,390 32,420 32,400 32,916 35,700 39,010 38,030 39,246 43,191 43,120
Total Revenue
70,749 65,299 65,058 66,832 67,684 70,950 76,118 80,187 82,006 84,039 84,284
Operating Revenue
70,749 65,299 65,058 66,832 67,684 70,950 76,118 80,187 82,006 84,039 84,284
Total Cost of Revenue
37,056 32,909 32,638 34,432 34,768 35,250 37,108 42,157 42,760 40,848 41,164
Operating Cost of Revenue
37,056 32,909 32,638 34,432 34,768 35,250 37,108 42,157 42,760 40,848 41,164
Total Operating Expenses
22,644 18,949 18,654 19,037 27,429 19,994 21,024 20,217 21,112 24,646 22,669
Selling, General & Admin Expense
20,616 18,949 18,654 19,037 19,084 19,994 21,024 20,217 21,112 23,305 22,669
Impairment Charge
- - 0.00 0.00 8,345 - - 0.00 0.00 1,341 0.00
Total Other Income / (Expense), net
-37 -72 -509 -37 582 128 -371 182 219 216 -284
Interest Expense
626 579 465 506 509 465 502 439 756 925 907
Interest & Investment Income
149 182 171 247 220 155 45 51 307 473 469
Other Income / (Expense), net
440 325 -215 222 871 438 86 570 668 668 154
Income Tax Expense
2,725 3,342 3,063 3,465 2,103 2,731 3,263 3,202 3,615 3,787 4,102
Net Income / (Loss) Attributable to Noncontrolling Interest
108 96 85 111 69 76 46 51 85 95 91
Basic Earnings per Share
$2.50 $3.80 $5.80 $3.75 $1.45 $5.13 $5.69 $6.00 $6.07 $6.18 $6.67
Weighted Average Basic Shares Outstanding
-16.75B 50.04B 2.60B 2.49B 2.50B 4.97B 4.85B 4.78B 4.71B 2.35B 2.34B
Diluted Earnings per Share
$2.44 $3.69 $5.59 $3.67 $1.43 $4.96 $5.50 $5.81 $5.90 $6.02 $6.51
Weighted Average Diluted Shares Outstanding
-16.75B 50.04B 2.60B 2.49B 2.50B 4.97B 4.85B 4.78B 4.71B 2.35B 2.34B
Weighted Average Basic & Diluted Shares Outstanding
-16.75B 50.04B 2.60B 2.49B 2.50B 4.97B 4.85B 4.78B 4.71B 2.35B 2.34B
Cash Dividends to Common per Share
$2.59 $2.66 $3.00 - $2.90 $3.03 $3.24 $3.52 $3.68 $3.83 $4.08

Quarterly Income Statements for Procter & Gamble

This table shows Procter & Gamble's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025
Period end date 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025
Net Income / (Loss) Attributable to Common Shareholders
3,933 3,397 3,384 4,521 3,468 3,754 3,136 3,959 4,630 3,769 3,616
Consolidated Net Income / (Loss)
3,959 3,424 3,392 4,556 3,493 3,781 3,144 3,987 4,659 3,793 3,626
Net Income / (Loss) Continuing Operations
3,959 3,424 3,392 4,556 3,493 3,780 3,145 3,988 4,658 3,793 3,626
Total Pre-Tax Income
4,835 4,288 4,233 5,802 4,496 4,592 3,871 5,140 5,845 4,661 4,521
Total Operating Income
4,785 4,248 4,162 5,767 4,433 4,460 3,885 5,797 5,741 4,558 4,355
Total Gross Profit
9,876 9,664 9,940 11,370 11,297 10,340 10,184 11,316 11,464 10,082 10,258
Total Revenue
20,773 20,068 20,553 21,871 21,441 20,195 20,532 21,737 21,882 19,776 20,889
Operating Revenue
20,773 20,068 20,553 21,871 21,441 20,195 20,532 21,737 21,882 19,776 20,889
Total Cost of Revenue
10,897 10,404 10,613 10,501 10,144 9,855 10,348 10,421 10,418 9,694 10,631
Operating Cost of Revenue
10,897 10,404 10,613 10,501 10,144 9,855 10,348 10,421 10,418 9,694 10,631
Total Operating Expenses
5,091 5,416 5,778 5,604 6,863 5,880 6,299 5,519 5,723 5,524 5,903
Selling, General & Admin Expense
5,091 5,416 5,778 5,604 5,522 5,880 6,299 5,519 5,723 5,524 5,903
Total Other Income / (Expense), net
50 40 71 35 62 131 -12 -657 103 104 166
Interest Expense
171 222 240 225 248 233 219 238 240 217 212
Interest & Investment Income
66 83 116 128 133 104 108 135 119 111 104
Other Income / (Expense), net
155 179 195 132 177 260 99 -554 224 210 274
Income Tax Expense
876 864 841 1,246 1,003 812 726 1,152 1,187 868 895
Net Income / (Loss) Attributable to Noncontrolling Interest
26 27 8.00 35 25 27 8.00 28 29 23 11
Basic Earnings per Share
$1.63 $1.41 $1.41 $1.89 $1.44 $1.56 $1.29 $1.65 $1.94 $1.58 $1.50
Weighted Average Basic Shares Outstanding
2.36B 2.36B 4.71B 2.36B 2.35B 2.36B 2.35B 2.36B 2.34B 2.34B 2.34B
Diluted Earnings per Share
$1.59 $1.37 $1.37 $1.83 $1.40 $1.52 $1.27 $1.61 $1.88 $1.54 $1.48
Weighted Average Diluted Shares Outstanding
2.36B 2.36B 4.71B 2.36B 2.35B 2.36B 2.35B 2.36B 2.34B 2.34B 2.34B
Weighted Average Basic & Diluted Shares Outstanding
2.36B 2.36B 4.71B 2.36B 2.35B 2.36B 2.35B 2.36B 2.34B 2.34B 2.34B

Annual Cash Flow Statements for Procter & Gamble

This table details how cash moves in and out of Procter & Gamble's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 6/30/2015 6/30/2016 6/30/2017 6/30/2018 6/30/2019 6/30/2020 6/30/2021 6/30/2022 6/30/2023 6/30/2024 6/30/2025
Net Change in Cash & Equivalents
-1,712 266 -2,529 -3,000 1,758 11,942 -5,893 -3,074 1,032 1,235 75
Net Cash From Operating Activities
14,608 15,435 12,753 14,867 15,242 17,403 18,371 16,723 16,848 19,846 17,817
Net Cash From Continuing Operating Activities
14,608 15,435 12,753 14,867 15,242 17,403 18,371 16,723 16,848 19,847 17,818
Net Income / (Loss) Continuing Operations
7,144 10,604 15,411 9,861 3,966 13,103 14,352 14,793 14,738 14,974 16,065
Consolidated Net Income / (Loss)
7,144 10,604 15,411 9,861 3,966 13,103 14,352 14,793 14,738 14,974 16,065
Depreciation Expense
3,134 3,078 2,820 2,834 2,824 3,013 2,735 2,807 2,714 2,896 2,847
Non-Cash Adjustments To Reconcile Net Income
4,519 928 -4,434 -1,279 8,495 -31 778 41 722 1,935 -273
Changes in Operating Assets and Liabilities, net
-189 825 -1,044 3,451 -43 1,318 506 -918 -1,326 42 -821
Net Cash From Investing Activities
-2,890 -5,575 -6,685 -3,511 -3,490 3,045 -2,834 -4,424 -3,500 -3,504 -3,818
Net Cash From Continuing Investing Activities
-2,890 -5,575 -6,210 -3,511 -3,490 3,045 -2,834 -4,424 -3,500 -3,504 -3,818
Purchase of Property, Plant & Equipment
-3,736 -3,314 -3,384 -3,717 -3,347 -3,073 -2,787 -3,156 -3,062 -3,322 -3,773
Acquisitions
-137 -186 -16 -109 -3,945 -58 -34 -1,381 -765 -21 -11
Sale of Property, Plant & Equipment
4,498 432 571 269 394 30 42 110 46 346 107
Sale and/or Maturity of Investments
1,040 1,447 1,488 3,955 3,628 6,146 -55 3.00 281 -507 -141
Net Cash From Financing Activities
-13,019 -9,213 -8,568 -14,375 -9,994 -8,367 -21,531 -14,876 -12,146 -14,855 -14,036
Net Cash From Continuing Financing Activities
-13,019 -9,213 -8,568 -14,375 -9,994 -8,367 -21,531 -14,876 -12,146 -14,855 -14,035
Repayment of Debt
-6,092 -2,631 -4,931 -6,310 -3,184 -14,473 -15,995 -12,904 -18,228 -9,167 -9,627
Repurchase of Common Equity
-4,604 -4,004 -5,204 -7,004 -5,003 -7,405 -11,009 -10,003 -7,353 -5,006 -6,500
Payment of Dividends
-7,287 -7,436 -7,236 -7,310 -7,498 -7,789 -8,263 -8,770 -8,999 -9,312 -9,872
Issuance of Debt
2,138 3,916 6,330 5,072 2,367 19,322 12,092 14,796 21,165 6,725 10,257
Other Financing Activities, net
2,826 942 2,473 1,177 3,324 1,978 1,644 2,005 1,269 1,905 1,707
Other Net Changes in Cash
- - - 19 - -139 101 -497 -170 -251 112
Cash Interest Paid
678 569 518 529 497 434 531 451 721 878 896
Cash Income Taxes Paid
4,558 3,730 3,714 2,830 3,064 3,550 3,822 3,818 4,278 4,363 4,554

Quarterly Cash Flow Statements for Procter & Gamble

This table details how cash moves in and out of Procter & Gamble's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025
Period end date 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025
Net Change in Cash & Equivalents
144 742 650 1,487 -1,843 -1,111 2,653 2,675 -1,927 -1,113 440
Net Cash From Operating Activities
3,574 3,863 5,341 4,904 5,100 4,088 5,754 4,302 4,825 3,705 4,985
Net Cash From Continuing Operating Activities
3,574 3,863 5,341 4,904 5,100 4,089 5,754 4,302 4,825 3,704 4,987
Net Income / (Loss) Continuing Operations
3,959 3,424 3,392 4,556 3,493 3,781 3,144 3,987 4,659 3,793 3,626
Consolidated Net Income / (Loss)
3,959 3,424 3,392 4,556 3,493 3,781 3,144 3,987 4,659 3,793 3,626
Depreciation Expense
653 692 706 702 721 712 761 728 706 690 723
Non-Cash Adjustments To Reconcile Net Income
-125 193 10 224 1,735 -442 1,140 1,083 80 201 -1,637
Changes in Operating Assets and Liabilities, net
-913 -446 1,233 -578 -849 38 709 -1,496 -620 -980 2,275
Net Cash From Investing Activities
-490 -1,380 -798 -1,222 -1,002 -762 -518 -1,108 -921 -726 -1,063
Net Cash From Continuing Investing Activities
-490 -1,380 -798 -1,222 -1,001 -763 -518 -1,108 -922 -727 -1,061
Purchase of Property, Plant & Equipment
-708 -730 -734 -925 -817 -797 -783 -993 -925 -859 -996
Sale of Property, Plant & Equipment
3.00 1.00 37 3.00 5.00 69 269 45 2.00 17 43
Sale and/or Maturity of Investments
289 -13 -50 -300 -189 - -4.00 -154 1.00 120 -108
Net Cash From Financing Activities
-2,993 -1,753 -3,893 -2,038 -6,049 -4,269 -2,499 -634 -5,571 -4,215 -3,616
Net Cash From Continuing Financing Activities
-2,993 -1,753 -3,893 -2,037 -6,052 -4,267 -2,499 -634 -5,570 -4,216 -3,615
Repayment of Debt
-6,481 -4,502 -6,830 -738 -3,719 670 -1,640 -1,085 -3,669 -1,048 -3,825
Repurchase of Common Equity
-2,002 -1,351 - -1,500 -1,003 -987 -1,516 -1,939 -2,510 -1,351 -700
Payment of Dividends
-2,231 -2,224 -2,289 -2,290 -2,288 -2,285 -2,449 -2,445 -2,441 -2,433 -2,553
Issuance of Debt
7,472 5,900 4,818 2,179 873 -2,233 2,166 4,090 2,810 - 3,357
Other Financing Activities, net
249 424 408 312 85 568 940 745 240 616 106

Annual Balance Sheets for Procter & Gamble

This table presents Procter & Gamble's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 6/30/2015 6/30/2016 6/30/2017 6/30/2018 6/30/2019 6/30/2020 6/30/2021 6/30/2022 6/30/2023 6/30/2024 6/30/2025
Total Assets
129,495 127,136 120,406 118,310 115,095 120,700 119,307 117,208 120,829 122,370 125,231
Total Current Assets
29,646 33,782 26,494 23,320 22,473 27,987 23,091 21,653 22,648 24,709 25,392
Cash & Equivalents
6,836 7,102 5,569 2,569 4,239 - 10,288 - 8,246 9,482 9,556
Accounts Receivable
4,568 4,373 4,594 4,686 4,951 4,178 4,725 5,143 5,471 6,118 6,185
Inventories, net
4,979 4,716 4,624 4,738 5,017 5,498 5,983 6,924 7,073 7,016 7,550
Prepaid Expenses
2,708 2,653 2,139 2,046 2,218 2,130 2,095 2,372 1,858 2,095 2,100
Plant, Property, & Equipment, net
19,655 19,385 19,893 20,600 21,271 20,692 21,686 21,195 21,909 22,152 23,897
Total Noncurrent Assets
80,194 73,969 74,019 74,390 71,351 72,021 74,530 74,360 76,272 75,508 75,941
Goodwill
44,622 44,350 44,699 45,175 40,273 39,901 40,924 39,700 40,659 40,303 41,650
Intangible Assets
25,010 24,527 24,187 23,902 24,215 23,792 23,642 23,679 23,783 22,047 21,910
Other Noncurrent Operating Assets
5,358 5,092 5,133 5,313 6,863 8,328 9,964 10,981 11,830 13,158 12,381
Total Liabilities & Shareholders' Equity
129,495 127,136 120,406 118,310 115,095 120,700 119,307 117,208 120,829 122,370 125,231
Total Liabilities
66,445 69,153 64,628 65,427 67,516 73,822 72,653 70,354 73,764 71,811 72,946
Total Current Liabilities
29,790 30,770 30,210 28,237 30,011 32,976 33,132 33,081 35,756 33,627 36,058
Short-Term Debt
12,018 11,653 13,554 10,423 9,697 11,183 8,889 8,645 10,229 7,191 9,513
Accounts Payable
8,138 9,325 9,632 10,344 11,260 12,071 13,720 14,882 14,598 15,364 15,227
Accrued Expenses
8,091 7,449 7,024 7,470 9,054 9,722 10,523 9,554 10,929 11,073 11,318
Total Noncurrent Liabilities
36,655 38,383 34,418 37,190 37,505 40,846 39,521 37,273 38,008 38,183 36,889
Long-Term Debt
18,327 18,945 18,038 20,863 20,395 23,537 23,099 22,848 24,378 25,269 24,995
Noncurrent Deferred & Payable Income Tax Liabilities
9,179 9,113 8,126 6,163 6,899 6,199 6,153 6,809 6,478 6,516 5,774
Other Noncurrent Operating Liabilities
8,432 10,325 8,254 10,164 10,211 11,110 10,269 7,616 7,152 6,398 6,120
Total Equity & Noncontrolling Interests
63,050 57,983 55,778 52,883 47,579 46,878 46,654 46,854 47,065 50,559 52,284
Total Preferred & Common Equity
62,419 57,341 55,184 52,293 47,194 46,424 46,308 46,589 46,777 50,286 52,012
Preferred Stock
1,077 1,038 1,006 967 928 800 800 843 819 798 777
Total Common Equity
61,342 56,303 54,178 51,326 46,266 45,624 45,508 45,746 45,958 49,488 51,235
Common Stock
67,861 67,723 67,650 67,855 67,836 68,203 68,857 69,804 70,565 71,693 72,779
Retained Earnings
84,807 87,953 96,124 98,641 94,918 100,239 106,374 112,429 118,170 123,811 129,973
Treasury Stock
-77,226 -82,176 -93,715 -99,217 -100,406 -105,573 -114,973 -123,382 -129,736 -133,379 -138,702
Accumulated Other Comprehensive Income / (Loss)
-12,780 -15,907 -14,632 -14,749 -14,936 -16,165 -13,744 -12,189 -12,220 -11,900 -12,143
Other Equity Adjustments
-1,320 -1,290 -1,249 -1,204 -1,146 -1,080 -1,006 -916 -821 -737 -672
Noncontrolling Interest
631 642 594 590 385 357 276 265 288 272 272

Quarterly Balance Sheets for Procter & Gamble

This table presents Procter & Gamble's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025
Period end date 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025
Total Assets
116,282 117,715 119,851 120,829 122,531 120,709 119,598 122,370 126,482 122,639 122,984
Total Current Assets
22,521 21,866 22,305 22,648 24,940 23,111 22,458 24,709 27,449 25,642 24,435
Cash & Equivalents
- - - 8,246 - - 6,828 9,482 12,156 10,230 9,116
Accounts Receivable
5,720 5,767 5,471 5,471 6,215 6,334 6,124 6,118 6,314 6,234 6,139
Inventories, net
7,590 7,541 7,483 7,073 7,117 7,152 7,078 7,016 7,287 7,020 7,400
Prepaid Expenses
2,501 1,704 1,755 1,858 1,875 1,736 2,428 2,095 1,692 2,158 1,780
Plant, Property, & Equipment, net
20,593 21,167 21,564 21,909 21,636 22,132 22,027 22,152 22,506 22,074 22,728
Total Noncurrent Assets
73,168 74,682 75,982 76,272 75,955 75,466 75,113 75,508 76,526 74,923 75,820
Goodwill
38,761 39,951 40,718 40,659 40,239 40,916 40,567 40,303 40,970 39,898 40,476
Intangible Assets
23,465 23,594 23,832 23,783 23,637 22,302 22,193 22,047 22,053 21,833 21,836
Other Noncurrent Operating Assets
10,942 11,137 11,432 11,830 12,079 12,248 12,353 13,158 13,503 13,192 13,508
Total Liabilities & Shareholders' Equity
116,282 117,715 119,851 120,829 122,531 120,709 119,598 122,370 126,482 122,639 122,984
Total Liabilities
71,948 72,990 74,430 73,764 74,517 71,880 69,264 71,811 74,341 71,195 70,439
Total Current Liabilities
36,618 38,746 38,030 35,756 37,158 35,950 32,340 33,627 36,420 33,797 34,248
Short-Term Debt
11,717 14,300 13,717 10,229 11,811 10,616 7,729 7,191 10,409 9,424 9,889
Accounts Payable
14,845 14,153 13,790 14,598 14,435 14,234 13,691 15,364 15,350 14,495 14,512
Accrued Expenses
10,056 10,293 10,523 10,929 10,912 11,100 10,921 11,073 10,661 9,879 9,847
Total Noncurrent Liabilities
35,330 34,244 36,400 38,008 37,360 35,929 36,923 38,183 37,921 37,399 36,191
Long-Term Debt
21,286 20,582 22,874 24,378 24,069 23,096 24,253 25,269 25,744 25,263 24,252
Noncurrent Deferred & Payable Income Tax Liabilities
6,986 6,462 6,422 6,478 6,814 6,219 6,284 6,516 6,420 6,725 6,481
Other Noncurrent Operating Liabilities
7,058 7,200 7,104 7,152 6,477 6,614 6,386 6,398 5,757 5,411 5,458
Total Equity & Noncontrolling Interests
44,334 44,725 45,421 47,065 48,014 48,829 50,333 50,559 52,141 51,443 52,545
Total Preferred & Common Equity
44,075 44,455 45,140 46,777 47,692 48,534 50,058 50,286 51,840 51,168 52,272
Preferred Stock
834 831 822 819 812 809 801 798 791 788 781
Total Common Equity
43,241 43,624 44,318 45,958 46,880 47,725 49,257 49,488 51,049 50,380 51,491
Common Stock
69,964 70,154 70,325 70,565 70,831 70,944 71,404 71,693 72,111 72,292 72,624
Retained Earnings
114,163 115,858 117,082 118,170 120,443 121,617 123,132 123,811 125,361 127,544 128,919
Treasury Stock
-127,205 -129,012 -130,002 -129,736 -131,029 -131,887 -132,172 -133,379 -134,823 -137,112 -138,073
Accumulated Other Comprehensive Income / (Loss)
-12,811 -12,506 -12,266 -12,220 -12,583 -12,167 -12,370 -11,900 -10,893 -11,637 -11,307
Other Equity Adjustments
-870 -870 -821 -821 -782 -782 -737 -737 -707 -707 -672
Noncontrolling Interest
259 270 281 288 321 294 275 272 300 275 273

Annual Metrics And Ratios for Procter & Gamble

This table displays calculated financial ratios and metrics derived from Procter & Gamble's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 6/30/2015 6/30/2016 6/30/2017 6/30/2018 6/30/2019 6/30/2020 6/30/2021 6/30/2022 6/30/2023 6/30/2024 6/30/2025
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-4.91% -7.70% -0.37% 2.73% 1.27% 4.83% 7.28% 5.35% 2.27% 2.48% 0.29%
EBITDA Growth
-15.28% 15.19% -2.81% 0.29% -44.08% 108.64% 8.61% 1.84% 1.54% 2.76% 6.07%
EBIT Growth
-18.63% 19.82% -1.56% 0.25% -53.20% 153.92% 11.94% 1.72% 2.28% 2.19% 7.25%
NOPAT Growth
-24.23% 21.24% 5.00% -6.58% -63.74% 262.47% 12.75% -0.07% -0.55% 1.64% 10.06%
Net Income Growth
-39.38% 48.43% 45.33% -36.01% -59.78% 230.38% 9.53% 3.07% -0.37% 1.60% 7.29%
EPS Growth
-39.15% 51.23% 51.49% -34.35% -61.04% 246.85% 10.89% 5.64% 1.55% 2.03% 8.14%
Operating Cash Flow Growth
4.66% 5.66% -17.38% 16.58% 2.52% 14.18% 5.56% -8.97% 0.75% 17.79% -10.22%
Free Cash Flow Firm Growth
107.01% -46.60% -38.02% 12.11% -13.08% 75.62% -21.70% 1.26% 3.41% 19.73% -14.26%
Invested Capital Growth
-19.57% -5.41% 2.62% 0.12% -6.82% -2.92% 4.49% 4.07% 3.22% 0.15% 5.03%
Revenue Q/Q Growth
5.55% -0.69% -0.04% 0.64% 0.88% 0.86% 1.67% 0.71% 1.28% -0.03% 0.43%
EBITDA Q/Q Growth
-7.42% 10.88% 0.53% -3.54% -44.28% 81.39% -0.16% 0.43% 2.85% -1.42% 2.66%
EBIT Q/Q Growth
-9.14% 13.36% 1.54% -4.45% -53.68% 114.05% 0.39% 0.43% 3.37% -1.90% 3.23%
NOPAT Q/Q Growth
-15.33% 18.36% 2.00% 0.28% -67.29% 165.85% 0.60% 0.87% 2.25% -1.20% 2.11%
Net Income Q/Q Growth
-22.57% 15.46% 1.61% -3.07% -64.25% 157.93% 0.86% 1.02% 2.32% -1.63% 3.09%
EPS Q/Q Growth
-22.54% 16.04% 2.38% -2.39% -66.03% 169.57% 1.29% 1.22% 2.79% -1.63% 3.33%
Operating Cash Flow Q/Q Growth
-3.42% 0.99% -3.42% 3.56% -0.31% 3.91% -3.59% -2.38% 10.70% 2.13% -4.14%
Free Cash Flow Firm Q/Q Growth
550.98% -3.44% -36.61% 69.44% -11.93% 4.43% -18.56% 14.45% 14.51% 5.61% -9.21%
Invested Capital Q/Q Growth
-7.14% -4.94% 2.26% -3.20% -11.34% -1.72% 2.42% 0.34% -1.33% -2.58% -0.43%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
47.62% 49.60% 49.83% 48.48% 48.63% 50.32% 51.25% 47.43% 47.86% 51.39% 51.16%
EBITDA Margin
20.67% 25.80% 25.16% 24.57% 13.57% 27.00% 27.34% 26.43% 26.24% 26.31% 27.83%
Operating Margin
15.62% 20.58% 21.16% 19.99% 8.11% 22.14% 23.63% 22.21% 22.11% 22.07% 24.26%
EBIT Margin
16.24% 21.08% 20.83% 20.33% 9.39% 22.75% 23.74% 22.93% 22.93% 22.86% 24.45%
Profit (Net Income) Margin
10.10% 16.24% 23.69% 14.75% 5.86% 18.47% 18.85% 18.45% 17.97% 17.82% 19.06%
Tax Burden Percent
64.87% 79.32% 116.25% 74.00% 65.35% 82.75% 81.48% 82.21% 80.30% 79.81% 79.66%
Interest Burden Percent
95.85% 97.12% 97.83% 98.09% 95.45% 98.08% 97.47% 97.89% 97.61% 97.65% 97.87%
Effective Tax Rate
24.75% 25.00% 23.10% 26.00% 34.65% 17.25% 18.52% 17.79% 19.70% 20.19% 20.34%
Return on Invested Capital (ROIC)
9.96% 13.92% 14.84% 13.68% 5.13% 19.57% 21.91% 21.00% 20.15% 20.14% 21.61%
ROIC Less NNEP Spread (ROIC-NNEP)
3.06% 18.32% 48.28% 13.53% 7.07% 20.13% 20.41% 21.65% 20.84% 20.84% 20.67%
Return on Net Nonoperating Assets (RNNOA)
0.78% 3.60% 12.25% 4.47% 2.76% 8.17% 8.78% 10.64% 11.24% 10.53% 9.63%
Return on Equity (ROE)
10.74% 17.52% 27.09% 18.15% 7.90% 27.74% 30.69% 31.64% 31.38% 30.68% 31.24%
Cash Return on Invested Capital (CROIC)
31.65% 19.48% 12.26% 13.56% 12.20% 22.54% 17.52% 17.01% 16.97% 19.99% 16.71%
Operating Return on Assets (OROA)
8.39% 10.73% 10.95% 11.38% 5.45% 13.69% 15.06% 15.54% 15.80% 15.80% 16.64%
Return on Assets (ROA)
5.22% 8.26% 12.45% 8.26% 3.40% 11.11% 11.96% 12.51% 12.38% 12.31% 12.98%
Return on Common Equity (ROCE)
10.45% 17.03% 26.31% 17.62% 7.67% 26.99% 29.90% 30.88% 30.64% 29.99% 30.60%
Return on Equity Simple (ROE_SIMPLE)
11.45% 18.49% 27.93% 18.86% 8.40% 28.22% 30.99% 31.75% 31.51% 29.78% 0.00%
Net Operating Profit after Tax (NOPAT)
8,315 10,081 10,585 9,888 3,586 12,997 14,654 14,643 14,562 14,802 16,291
NOPAT Margin
11.75% 15.44% 16.27% 14.80% 5.30% 18.32% 19.25% 18.26% 17.76% 17.61% 19.33%
Net Nonoperating Expense Percent (NNEP)
6.91% -4.40% -33.44% 0.15% -1.94% -0.55% 1.50% -0.65% -0.69% -0.70% 0.94%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - - - - 18.77%
Cost of Revenue to Revenue
52.38% 50.40% 50.17% 51.52% 51.37% 49.68% 48.75% 52.57% 52.14% 48.61% 48.84%
SG&A Expenses to Revenue
29.14% 29.02% 28.67% 28.48% 28.20% 28.18% 27.62% 25.21% 25.74% 27.73% 26.90%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
32.01% 29.02% 28.67% 28.48% 40.53% 28.18% 27.62% 25.21% 25.74% 29.33% 26.90%
Earnings before Interest and Taxes (EBIT)
11,489 13,766 13,551 13,585 6,358 16,144 18,072 18,383 18,802 19,213 20,605
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
14,623 16,844 16,371 16,419 9,182 19,157 20,807 21,190 21,516 22,109 23,452
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
2.70 3.23 3.43 3.29 5.28 5.91 6.78 7.12 7.54 7.82 7.24
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
2.34 2.79 2.85 2.53 3.61 3.80 4.05 4.06 4.23 4.60 4.40
Price to Earnings (P/E)
23.55 17.32 12.11 17.32 62.73 20.71 21.57 22.10 23.66 26.00 23.23
Dividend Yield
4.25% 4.86% 3.72% 4.15% 2.97% 2.78% 2.57% 2.59% 2.50% 2.34% 2.58%
Earnings Yield
4.25% 5.77% 8.25% 5.77% 1.59% 4.83% 4.64% 4.53% 4.23% 3.85% 4.31%
Enterprise Value to Invested Capital (EV/IC)
2.50 2.85 2.82 2.62 3.94 4.43 4.85 4.94 5.09 5.59 5.14
Enterprise Value to Revenue (EV/Rev)
2.63 3.08 3.13 2.84 3.92 4.08 4.35 4.38 4.56 4.89 4.71
Enterprise Value to EBITDA (EV/EBITDA)
12.73 11.93 12.44 11.56 28.92 15.11 15.92 16.57 17.39 18.59 16.93
Enterprise Value to EBIT (EV/EBIT)
16.20 14.60 15.03 13.97 41.77 17.94 18.33 19.10 19.90 21.39 19.27
Enterprise Value to NOPAT (EV/NOPAT)
22.39 19.93 19.25 19.20 74.06 22.28 22.61 23.98 25.69 27.76 24.37
Enterprise Value to Operating Cash Flow (EV/OCF)
12.74 13.02 15.97 12.77 17.42 16.64 18.03 21.00 22.20 20.71 22.28
Enterprise Value to Free Cash Flow (EV/FCFF)
7.05 14.24 23.30 19.37 31.17 19.35 28.27 29.60 30.49 27.98 31.52
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.48 0.53 0.57 0.59 0.63 0.74 0.69 0.67 0.74 0.64 0.66
Long-Term Debt to Equity
0.29 0.33 0.32 0.39 0.43 0.50 0.50 0.49 0.52 0.50 0.48
Financial Leverage
0.25 0.20 0.25 0.33 0.39 0.41 0.43 0.49 0.54 0.51 0.47
Leverage Ratio
2.06 2.12 2.18 2.20 2.32 2.50 2.57 2.53 2.53 2.49 2.41
Compound Leverage Factor
1.97 2.06 2.13 2.16 2.22 2.45 2.50 2.48 2.47 2.43 2.36
Debt to Total Capital
32.49% 34.54% 36.16% 37.17% 38.74% 42.55% 40.68% 40.20% 42.37% 39.10% 39.76%
Short-Term Debt to Total Capital
12.87% 13.16% 15.51% 12.38% 12.48% 13.71% 11.30% 11.03% 12.52% 8.66% 10.96%
Long-Term Debt to Total Capital
19.62% 21.39% 20.65% 24.79% 26.26% 28.85% 29.37% 29.16% 29.85% 30.44% 28.80%
Preferred Equity to Total Capital
1.15% 1.17% 1.15% 1.15% 1.19% 0.98% 1.02% 1.08% 1.00% 0.96% 0.90%
Noncontrolling Interests to Total Capital
0.68% 0.72% 0.68% 0.70% 0.50% 0.44% 0.35% 0.34% 0.35% 0.33% 0.31%
Common Equity to Total Capital
65.68% 63.56% 62.01% 60.98% 59.57% 55.91% 57.87% 58.39% 56.27% 59.61% 59.03%
Debt to EBITDA
2.08 1.82 1.93 1.91 3.28 1.81 1.54 1.49 1.61 1.47 1.47
Net Debt to EBITDA
1.28 1.02 1.01 1.18 2.16 0.97 1.04 1.15 1.23 1.04 1.06
Long-Term Debt to EBITDA
1.25 1.12 1.10 1.27 2.22 1.23 1.11 1.08 1.13 1.14 1.07
Debt to NOPAT
3.65 3.04 2.98 3.16 8.39 2.67 2.18 2.15 2.38 2.19 2.12
Net Debt to NOPAT
2.25 1.71 1.55 1.97 5.52 1.43 1.48 1.66 1.81 1.55 1.53
Long-Term Debt to NOPAT
2.20 1.88 1.70 2.11 5.69 1.81 1.58 1.56 1.67 1.71 1.53
Altman Z-Score
3.25 3.45 3.72 3.61 4.02 4.34 4.83 5.21 5.25 5.77 5.62
Noncontrolling Interest Sharing Ratio
2.69% 2.80% 2.88% 2.91% 2.86% 2.72% 2.57% 2.41% 2.36% 2.23% 2.06%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.00 1.10 0.88 0.83 0.75 0.85 0.70 0.65 0.63 0.73 0.70
Quick Ratio
0.54 0.58 0.65 0.59 0.51 0.13 0.45 0.16 0.38 0.46 0.44
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
26,417 14,106 8,743 9,802 8,521 14,964 11,717 11,864 12,269 14,690 12,595
Operating Cash Flow to CapEx
0.00% 535.57% 453.36% 431.18% 516.15% 571.90% 669.25% 549.02% 558.62% 666.87% 486.01%
Free Cash Flow to Firm to Interest Expense
42.20 24.36 18.80 19.37 16.74 32.18 23.34 27.03 16.23 15.88 13.89
Operating Cash Flow to Interest Expense
23.34 26.66 27.43 29.38 29.95 37.43 36.60 38.09 22.29 21.46 19.64
Operating Cash Flow Less CapEx to Interest Expense
24.55 21.68 21.38 22.57 24.14 30.88 31.13 31.15 18.30 18.24 15.60
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.52 0.51 0.53 0.56 0.58 0.60 0.63 0.68 0.69 0.69 0.68
Accounts Receivable Turnover
12.92 14.61 14.51 14.40 14.05 15.54 17.10 16.25 15.45 14.50 13.70
Inventory Turnover
6.31 6.79 6.99 7.36 7.13 6.70 6.46 6.53 6.11 5.80 5.65
Fixed Asset Turnover
3.37 3.35 3.31 3.30 3.23 3.38 3.59 3.74 3.81 3.81 3.66
Accounts Payable Turnover
4.46 3.77 3.44 3.45 3.22 3.02 2.88 2.95 2.90 2.73 2.69
Days Sales Outstanding (DSO)
28.26 24.99 25.15 25.34 25.98 23.48 21.35 22.46 23.62 25.17 26.64
Days Inventory Outstanding (DIO)
57.81 53.76 52.23 49.62 51.20 54.44 56.46 55.88 59.74 62.95 64.58
Days Payable Outstanding (DPO)
81.75 96.84 106.00 105.88 113.40 120.79 126.84 123.82 125.82 133.86 135.62
Cash Conversion Cycle (CCC)
4.32 -18.09 -28.62 -30.92 -36.21 -42.87 -49.03 -45.49 -42.46 -45.75 -44.41
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
74,416 70,391 72,233 72,319 67,384 65,417 68,354 71,133 73,426 73,538 77,234
Invested Capital Turnover
0.85 0.90 0.91 0.92 0.97 1.07 1.14 1.15 1.13 1.14 1.12
Increase / (Decrease) in Invested Capital
-18,102 -4,025 1,842 86 -4,935 -1,967 2,937 2,779 2,293 112 3,696
Enterprise Value (EV)
186,145 200,934 203,721 189,826 265,560 289,544 331,297 351,159 374,097 410,956 396,997
Market Capitalization
165,695 182,004 185,666 168,833 244,442 269,848 308,521 325,772 346,629 386,908 370,996
Book Value per Share
$22.61 $21.15 $21.18 $20.41 $18.44 $18.43 $18.59 $19.07 $19.50 $20.97 $21.85
Tangible Book Value per Share
($3.06) ($4.72) ($5.75) ($7.06) ($7.26) ($7.30) ($7.78) ($7.35) ($7.84) ($5.45) ($5.26)
Total Capital
93,395 88,581 87,370 84,169 77,671 81,598 78,642 78,347 81,672 83,019 86,792
Total Debt
30,345 30,598 31,592 31,286 30,092 34,720 31,988 31,493 34,607 32,460 34,508
Total Long-Term Debt
18,327 18,945 18,038 20,863 20,395 23,537 23,099 22,848 24,378 25,269 24,995
Net Debt
18,742 17,250 16,455 19,436 19,805 18,539 21,700 24,279 26,361 22,978 24,952
Capital Expenditures (CapEx)
-762 2,882 2,813 3,448 2,953 3,043 2,745 3,046 3,016 2,976 3,666
Debt-free, Cash-free Net Working Capital (DFCFNWC)
271 1,317 -5,299 -6,344 -8,128 -9,987 -11,440 -9,997 -11,125 -11,209 -10,709
Debt-free Net Working Capital (DFNWC)
11,874 14,665 9,838 5,506 2,159 6,194 -1,152 -2,783 -2,879 -1,727 -1,153
Net Working Capital (NWC)
-144 3,012 -3,716 -4,917 -7,538 -4,989 -10,041 -11,428 -13,108 -8,918 -10,666
Net Nonoperating Expense (NNE)
1,171 -523 -4,826 27 -380 -106 302 -150 -176 -172 226
Net Nonoperating Obligations (NNO)
11,366 12,408 16,455 19,436 19,805 18,539 21,700 24,279 26,361 22,979 24,950
Total Depreciation and Amortization (D&A)
3,134 3,078 2,820 2,834 2,824 3,013 2,735 2,807 2,714 2,896 2,847
Debt-free, Cash-free Net Working Capital to Revenue
0.38% 2.02% -8.15% -9.49% -12.01% -14.08% -15.03% -12.47% -13.57% -13.34% -12.71%
Debt-free Net Working Capital to Revenue
16.78% 22.46% 15.12% 8.24% 3.19% 8.73% -1.51% -3.47% -3.51% -2.06% -1.37%
Net Working Capital to Revenue
-0.20% 4.61% -5.71% -7.36% -11.14% -7.03% -13.19% -14.25% -15.98% -10.61% -12.65%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$2.50 $3.80 $5.80 $0.00 $1.45 $5.13 $5.69 $6.00 $6.07 $6.18 $6.67
Adjusted Weighted Average Basic Shares Outstanding
2.71B 2.67B 2.55B 0.00 2.50B 4.97B 4.85B 4.78B 4.71B 2.35B 2.34B
Adjusted Diluted Earnings per Share
$2.44 $3.69 $5.59 $0.00 $1.43 $4.96 $5.50 $5.81 $5.90 $6.02 $6.51
Adjusted Weighted Average Diluted Shares Outstanding
2.71B 2.67B 2.55B 0.00 2.50B 4.97B 4.85B 4.78B 4.71B 2.35B 2.34B
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
2.71B 2.67B 2.55B 0.00 2.50B 4.97B 4.85B 4.78B 4.71B 2.35B 2.34B
Normalized Net Operating Profit after Tax (NOPAT)
8,315 10,081 10,585 9,888 9,039 12,997 14,654 14,643 14,562 15,872 16,291
Normalized NOPAT Margin
11.75% 15.44% 16.27% 14.80% 13.35% 18.32% 19.25% 18.26% 17.76% 18.89% 19.33%
Pre Tax Income Margin
15.56% 20.47% 20.38% 19.94% 8.97% 22.32% 23.14% 22.44% 22.38% 22.32% 23.93%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
18.35 23.78 29.14 26.85 12.49 34.72 36.00 41.87 24.87 20.77 22.72
NOPAT to Interest Expense
13.28 17.41 22.76 19.54 7.04 27.95 29.19 33.36 19.26 16.00 17.96
EBIT Less CapEx to Interest Expense
19.57 18.80 23.09 20.03 6.69 28.17 30.53 34.94 20.88 17.55 18.68
NOPAT Less CapEx to Interest Expense
14.50 12.43 16.71 12.73 1.24 21.41 23.72 26.42 15.27 12.78 13.92
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
102.00% 70.12% 46.95% 74.13% 189.06% 59.44% 57.57% 59.28% 61.06% 62.19% 61.45%
Augmented Payout Ratio
166.45% 107.88% 80.72% 145.16% 315.20% 115.96% 134.28% 126.90% 110.95% 95.62% 101.91%

Quarterly Metrics And Ratios for Procter & Gamble

This table displays calculated financial ratios and metrics derived from Procter & Gamble's official financial filings.

Metric Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025
Period end date 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-0.86% 3.54% 5.32% 6.11% 3.22% 0.63% -0.10% -0.61% 2.06% -2.07% 1.74%
EBITDA Growth
-7.08% 5.31% 13.37% 14.98% -4.68% 6.11% -6.28% -9.54% 25.14% 0.48% 12.79%
EBIT Growth
-7.40% 6.14% 16.37% 16.17% -6.68% 6.62% -8.56% -11.12% 29.39% 1.02% 16.19%
NOPAT Growth
-6.37% 1.92% 10.64% 15.61% -12.10% 8.23% -5.36% -0.68% 32.84% 1.03% 10.66%
Net Income Growth
-6.67% 1.69% 10.92% 14.96% -11.77% 10.43% -7.31% -12.49% 33.38% 0.32% 15.33%
EPS Growth
-4.22% 3.01% 13.22% 16.56% -11.95% 10.95% -7.30% -12.02% 34.29% 1.32% 16.54%
Operating Cash Flow Growth
-30.21% 19.01% 43.85% 20.49% 42.70% 5.82% 7.73% -12.28% -5.39% -9.37% -13.36%
Free Cash Flow Firm Growth
-94.20% 83.60% 342.63% -46.91% 824.26% 2,026.29% 192.14% 153.21% 115.61% -37.36% -106.67%
Invested Capital Growth
5.44% 4.98% 3.22% 5.00% 2.61% 1.44% 0.15% 2.67% 1.67% 2.76% 5.03%
Revenue Q/Q Growth
0.78% -3.39% 2.42% 6.41% -1.97% -5.81% 1.67% 5.87% 0.67% -9.62% 5.63%
EBITDA Q/Q Growth
-2.58% -8.47% -1.09% 30.38% -19.24% 1.89% -12.65% 25.84% 11.72% -18.18% -1.94%
EBIT Q/Q Growth
-2.72% -10.38% -1.58% 35.39% -21.85% 2.39% -15.59% 31.60% 13.77% -20.07% -2.92%
NOPAT Q/Q Growth
0.03% -13.43% -1.68% 35.78% -23.95% 6.60% -14.03% 42.50% 1.72% -18.93% -5.83%
Net Income Q/Q Growth
-0.10% -13.51% -0.93% 34.32% -23.33% 8.25% -16.85% 26.81% 16.85% -18.59% -4.40%
EPS Q/Q Growth
1.27% -13.84% 0.00% 33.58% -23.50% 8.57% -16.45% 26.77% 16.77% -18.09% -3.90%
Operating Cash Flow Q/Q Growth
-12.19% 8.09% 38.26% -8.18% 4.00% -19.84% 40.75% -25.23% 12.16% -23.21% 34.55%
Free Cash Flow Firm Q/Q Growth
-91.09% -180.77% 872.27% -4.47% 55.10% 68.35% 17.12% -17.20% 32.07% -51.09% -112.48%
Invested Capital Q/Q Growth
3.01% 2.29% -1.33% 1.00% 0.66% 1.12% -2.58% 3.53% -0.31% 2.20% -0.43%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
47.54% 48.16% 48.36% 51.99% 52.69% 51.20% 49.60% 52.06% 52.39% 50.98% 49.11%
EBITDA Margin
26.92% 25.51% 24.63% 30.18% 24.86% 26.90% 23.11% 27.47% 30.49% 27.60% 25.62%
Operating Margin
23.03% 21.17% 20.25% 26.37% 20.68% 22.08% 18.92% 26.67% 26.24% 23.05% 20.85%
EBIT Margin
23.78% 22.06% 21.20% 26.97% 21.50% 23.37% 19.40% 24.12% 27.26% 24.11% 22.16%
Profit (Net Income) Margin
19.06% 17.06% 16.50% 20.83% 16.29% 18.72% 15.31% 18.34% 21.29% 19.18% 17.36%
Tax Burden Percent
81.88% 79.85% 80.13% 78.52% 77.69% 82.34% 81.22% 77.57% 79.71% 81.38% 80.20%
Interest Burden Percent
97.87% 96.86% 97.15% 98.36% 97.53% 97.29% 97.16% 98.04% 97.99% 97.76% 97.67%
Effective Tax Rate
18.12% 20.15% 19.87% 21.48% 22.31% 17.68% 18.75% 22.41% 20.31% 18.62% 19.80%
Return on Invested Capital (ROIC)
21.36% 18.84% 18.41% 23.82% 18.29% 20.39% 17.58% 23.10% 23.43% 20.57% 18.69%
ROIC Less NNEP Spread (ROIC-NNEP)
21.52% 18.96% 18.64% 23.92% 18.47% 20.79% 17.53% 21.07% 23.76% 20.90% 19.25%
Return on Net Nonoperating Assets (RNNOA)
12.52% 11.26% 10.05% 13.58% 10.63% 11.76% 8.86% 10.55% 11.91% 10.20% 8.97%
Return on Equity (ROE)
33.88% 30.09% 28.46% 37.40% 28.93% 32.15% 26.44% 33.65% 35.34% 30.76% 27.67%
Cash Return on Invested Capital (CROIC)
14.71% 14.75% 16.97% 16.08% 17.37% 18.56% 19.99% 17.04% 19.49% 18.13% 16.71%
Operating Return on Assets (OROA)
15.97% 14.88% 14.61% 18.81% 15.14% 16.41% 13.41% 16.25% 18.90% 16.68% 15.09%
Return on Assets (ROA)
12.80% 11.51% 11.37% 14.53% 11.47% 13.15% 10.58% 12.36% 14.76% 13.27% 11.82%
Return on Common Equity (ROCE)
33.04% 29.36% 27.79% 36.50% 28.24% 31.42% 25.85% 32.90% 34.58% 30.13% 27.10%
Return on Equity Simple (ROE_SIMPLE)
32.27% 31.91% 0.00% 32.15% 30.63% 30.41% 0.00% 27.79% 30.43% 29.81% 0.00%
Net Operating Profit after Tax (NOPAT)
3,918 3,392 3,335 4,529 3,444 3,671 3,156 4,498 4,575 3,709 3,493
NOPAT Margin
18.86% 16.90% 16.23% 20.71% 16.06% 18.18% 15.37% 20.69% 20.91% 18.76% 16.72%
Net Nonoperating Expense Percent (NNEP)
-0.16% -0.12% -0.22% -0.10% -0.18% -0.41% 0.05% 2.04% -0.33% -0.33% -0.56%
Return On Investment Capital (ROIC_SIMPLE)
- - - - 4.17% - - - 5.31% 4.28% 4.02%
Cost of Revenue to Revenue
52.46% 51.84% 51.64% 48.01% 47.31% 48.80% 50.40% 47.94% 47.61% 49.02% 50.89%
SG&A Expenses to Revenue
24.51% 26.99% 28.11% 25.62% 25.75% 29.12% 30.68% 25.39% 26.15% 27.93% 28.26%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
24.51% 26.99% 28.11% 25.62% 32.01% 29.12% 30.68% 25.39% 26.15% 27.93% 28.26%
Earnings before Interest and Taxes (EBIT)
4,940 4,427 4,357 5,899 4,610 4,720 3,984 5,243 5,965 4,768 4,629
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
5,593 5,119 5,063 6,601 5,331 5,432 4,745 5,971 6,671 5,458 5,352
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
7.98 7.67 7.54 7.11 7.06 7.70 7.82 7.94 7.84 7.71 7.24
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
4.34 4.20 4.23 4.00 4.02 4.51 4.60 4.83 4.68 4.73 4.40
Price to Earnings (P/E)
24.38 23.73 23.66 21.88 22.82 25.08 26.00 28.31 25.51 25.63 23.23
Dividend Yield
2.46% 2.54% 2.50% 2.62% 2.61% 2.33% 2.34% 2.26% 2.36% 2.38% 2.58%
Earnings Yield
4.10% 4.21% 4.23% 4.57% 4.38% 3.99% 3.85% 3.53% 3.92% 3.90% 4.31%
Enterprise Value to Invested Capital (EV/IC)
5.18 4.97 5.09 4.86 4.87 5.37 5.59 5.65 5.54 5.46 5.14
Enterprise Value to Revenue (EV/Rev)
4.70 4.57 4.56 4.33 4.34 4.82 4.89 5.13 4.98 5.04 4.71
Enterprise Value to EBITDA (EV/EBITDA)
18.26 17.69 17.39 16.12 16.46 18.08 18.59 20.04 18.42 18.53 16.93
Enterprise Value to EBIT (EV/EBIT)
21.03 20.34 19.90 18.38 18.86 20.71 21.39 23.19 21.11 21.20 19.27
Enterprise Value to NOPAT (EV/NOPAT)
26.60 25.98 25.69 23.77 24.76 27.07 27.76 29.11 26.40 26.53 24.37
Enterprise Value to Operating Cash Flow (EV/OCF)
25.83 24.31 22.20 20.40 18.95 20.87 20.71 22.37 22.16 22.77 22.28
Enterprise Value to Free Cash Flow (EV/FCFF)
36.18 34.53 30.49 30.98 28.43 29.16 27.98 33.61 28.65 30.51 31.52
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.78 0.81 0.74 0.75 0.69 0.64 0.64 0.69 0.67 0.65 0.66
Long-Term Debt to Equity
0.46 0.50 0.52 0.50 0.47 0.48 0.50 0.49 0.49 0.46 0.48
Financial Leverage
0.58 0.59 0.54 0.57 0.58 0.57 0.51 0.50 0.50 0.49 0.47
Leverage Ratio
2.67 2.63 2.53 2.59 2.55 2.50 2.49 2.49 2.43 2.36 2.41
Compound Leverage Factor
2.61 2.55 2.46 2.54 2.49 2.43 2.42 2.44 2.38 2.31 2.35
Debt to Total Capital
43.82% 44.62% 42.37% 42.77% 40.84% 38.85% 39.10% 40.95% 40.27% 39.38% 39.76%
Short-Term Debt to Total Capital
17.96% 16.73% 12.52% 14.08% 12.86% 9.39% 8.66% 11.79% 10.94% 11.41% 10.96%
Long-Term Debt to Total Capital
25.85% 27.89% 29.85% 28.69% 27.98% 29.46% 30.44% 29.16% 29.33% 27.98% 28.80%
Preferred Equity to Total Capital
1.04% 1.00% 1.00% 0.97% 0.98% 0.97% 0.96% 0.90% 0.91% 0.90% 0.90%
Noncontrolling Interests to Total Capital
0.34% 0.34% 0.35% 0.38% 0.36% 0.33% 0.33% 0.34% 0.32% 0.31% 0.31%
Common Equity to Total Capital
54.80% 54.04% 56.27% 55.88% 57.82% 59.84% 59.61% 57.82% 58.49% 59.40% 59.03%
Debt to EBITDA
1.69 1.75 1.61 1.60 1.52 1.43 1.47 1.68 1.52 1.49 1.47
Net Debt to EBITDA
1.36 1.39 1.23 1.17 1.17 1.12 1.04 1.12 1.07 1.10 1.06
Long-Term Debt to EBITDA
1.00 1.09 1.13 1.08 1.04 1.08 1.14 1.20 1.11 1.06 1.07
Debt to NOPAT
2.46 2.57 2.38 2.36 2.29 2.13 2.19 2.45 2.18 2.14 2.12
Net Debt to NOPAT
1.98 2.04 1.81 1.72 1.76 1.68 1.55 1.62 1.54 1.57 1.53
Long-Term Debt to NOPAT
1.45 1.61 1.67 1.59 1.57 1.62 1.71 1.74 1.59 1.52 1.53
Altman Z-Score
4.89 4.75 4.86 4.78 4.92 5.46 5.36 5.37 5.55 5.57 5.20
Noncontrolling Interest Sharing Ratio
2.49% 2.43% 2.36% 2.41% 2.36% 2.28% 2.23% 2.22% 2.16% 2.07% 2.06%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
0.56 0.59 0.63 0.67 0.64 0.69 0.73 0.75 0.76 0.71 0.70
Quick Ratio
0.15 0.14 0.38 0.17 0.18 0.40 0.46 0.51 0.49 0.45 0.44
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
167 -135 1,042 996 1,544 2,599 3,044 2,521 3,329 1,628 -203
Operating Cash Flow to CapEx
506.95% 529.90% 766.28% 531.89% 628.08% 561.54% 1,119.46% 453.80% 522.75% 440.02% 523.09%
Free Cash Flow to Firm to Interest Expense
0.98 -0.61 4.34 4.42 6.23 11.16 13.90 10.59 13.87 7.50 -0.96
Operating Cash Flow to Interest Expense
20.90 17.40 22.25 21.80 20.56 17.55 26.27 18.08 20.10 17.07 23.51
Operating Cash Flow Less CapEx to Interest Expense
16.78 14.12 19.35 17.70 17.29 14.42 23.93 14.09 16.26 13.19 19.02
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.67 0.67 0.69 0.70 0.70 0.70 0.69 0.67 0.69 0.69 0.68
Accounts Receivable Turnover
14.59 14.74 15.45 13.95 13.87 14.50 14.50 13.39 13.42 13.69 13.70
Inventory Turnover
6.03 5.89 6.11 5.77 5.67 5.65 5.80 5.66 5.79 5.65 5.65
Fixed Asset Turnover
3.78 3.78 3.81 3.94 3.88 3.86 3.81 3.80 3.82 3.75 3.66
Accounts Payable Turnover
3.03 3.07 2.90 2.90 2.94 2.99 2.73 2.74 2.86 2.90 2.69
Days Sales Outstanding (DSO)
25.02 24.76 23.62 26.16 26.31 25.17 25.17 27.25 27.19 26.67 26.64
Days Inventory Outstanding (DIO)
60.51 61.97 59.74 63.28 64.36 64.64 62.95 64.48 63.02 64.63 64.58
Days Payable Outstanding (DPO)
120.50 118.83 125.82 125.98 124.35 121.99 133.86 133.33 127.75 125.90 135.62
Cash Conversion Cycle (CCC)
-34.97 -32.10 -42.46 -36.54 -33.67 -32.18 -45.75 -41.60 -37.54 -34.60 -44.41
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
72,753 74,416 73,426 74,160 74,653 75,488 73,538 76,137 75,899 77,569 77,234
Invested Capital Turnover
1.13 1.11 1.13 1.15 1.14 1.12 1.14 1.12 1.12 1.10 1.12
Increase / (Decrease) in Invested Capital
3,751 3,527 2,293 3,533 1,900 1,072 112 1,977 1,246 2,081 3,696
Enterprise Value (EV)
377,192 369,990 374,097 360,665 363,917 405,560 410,956 430,428 420,343 423,214 396,997
Market Capitalization
348,063 339,892 346,629 333,385 336,992 379,330 386,908 405,340 394,823 397,135 370,996
Book Value per Share
$18.41 $18.79 $19.50 $19.89 $20.25 $20.93 $20.97 $21.69 $21.39 $21.96 $21.85
Tangible Book Value per Share
($8.41) ($8.58) ($7.84) ($7.21) ($6.57) ($5.74) ($5.45) ($5.09) ($4.82) ($4.61) ($5.26)
Total Capital
79,607 82,012 81,672 83,894 82,541 82,315 83,019 88,294 86,130 86,686 86,792
Total Debt
34,882 36,591 34,607 35,880 33,712 31,982 32,460 36,153 34,687 34,141 34,508
Total Long-Term Debt
20,582 22,874 24,378 24,069 23,096 24,253 25,269 25,744 25,263 24,252 24,995
Net Debt
28,028 28,995 26,361 26,147 25,822 25,154 22,978 23,997 24,457 25,025 24,952
Capital Expenditures (CapEx)
705 729 697 922 812 728 514 948 923 842 953
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-9,434 -9,604 -11,125 -10,140 -10,113 -8,981 -11,209 -10,718 -8,961 -9,040 -10,709
Debt-free Net Working Capital (DFNWC)
-2,580 -2,008 -2,879 -407 -2,223 -2,153 -1,727 1,438 1,269 76 -1,153
Net Working Capital (NWC)
-16,880 -15,725 -13,108 -12,218 -12,839 -9,882 -8,918 -8,971 -8,155 -9,813 -10,666
Net Nonoperating Expense (NNE)
-41 -32 -57 -27 -49 -110 12 511 -84 -84 -133
Net Nonoperating Obligations (NNO)
28,028 28,995 26,361 26,146 25,824 25,155 22,979 23,996 24,456 25,024 24,950
Total Depreciation and Amortization (D&A)
653 692 706 702 721 712 761 728 706 690 723
Debt-free, Cash-free Net Working Capital to Revenue
-11.75% -11.86% -13.57% -12.18% -12.05% -10.68% -13.34% -12.77% -10.62% -10.77% -12.71%
Debt-free Net Working Capital to Revenue
-3.21% -2.48% -3.51% -0.49% -2.65% -2.56% -2.06% 1.71% 1.50% 0.09% -1.37%
Net Working Capital to Revenue
-21.03% -19.42% -15.98% -14.67% -15.30% -11.76% -10.61% -10.69% -9.67% -11.69% -12.65%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$1.63 $1.41 $1.41 $1.89 $1.44 $1.56 $1.29 $1.65 $1.94 $1.58 $1.50
Adjusted Weighted Average Basic Shares Outstanding
2.36B 2.36B 4.71B 2.36B 2.35B 2.36B 2.35B 2.36B 2.34B 2.34B 2.34B
Adjusted Diluted Earnings per Share
$1.59 $1.37 $1.37 $1.83 $1.40 $1.52 $1.27 $1.61 $1.88 $1.54 $1.48
Adjusted Weighted Average Diluted Shares Outstanding
2.48B 2.47B 4.71B 2.36B 2.35B 2.36B 2.35B 2.36B 2.34B 2.34B 2.34B
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
2.36B 2.36B 4.71B 2.36B 2.35B 2.36B 2.35B 2.36B 2.34B 2.34B 2.34B
Normalized Net Operating Profit after Tax (NOPAT)
3,918 3,392 3,335 4,529 4,486 3,671 3,156 4,498 4,575 3,709 3,493
Normalized NOPAT Margin
18.86% 16.90% 16.23% 20.71% 20.92% 18.18% 15.37% 20.69% 20.91% 18.76% 16.72%
Pre Tax Income Margin
23.28% 21.37% 20.60% 26.53% 20.97% 22.74% 18.85% 23.65% 26.71% 23.57% 21.64%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
28.89 19.94 18.15 26.22 18.59 20.26 18.19 22.03 24.85 21.97 21.83
NOPAT to Interest Expense
22.91 15.28 13.90 20.13 13.89 15.76 14.41 18.90 19.06 17.09 16.48
EBIT Less CapEx to Interest Expense
24.77 16.66 15.25 22.12 15.31 17.13 15.84 18.05 21.01 18.09 17.34
NOPAT Less CapEx to Interest Expense
18.79 12.00 10.99 16.03 10.61 12.63 12.07 14.91 15.22 13.21 11.98
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
62.05% 62.29% 61.06% 58.93% 61.16% 60.12% 62.19% 65.72% 61.78% 62.68% 61.45%
Augmented Payout Ratio
121.31% 122.01% 110.95% 90.58% 87.08% 83.05% 95.62% 103.52% 106.43% 109.63% 101.91%

Key Financial Trends

Procter & Gamble (PG) Financial Summary and Trends (Q3 2021 to Q4 2025)

Over the examined period, Procter & Gamble demonstrated steady financial performance with growth in revenues, profitability, and consistent cash flow generation.

  • Revenue Growth: Operating revenue increased from approximately $19.7 billion in Q2 2021 to about $20.9 billion in Q4 2025, displaying steady growth over the years.
  • Profitability Gains: Net income attributable to common shareholders rose from roughly $3.9 billion (Q2 2021) to around $3.6 billion (Q4 2025), with quarterly EPS gradually improving from $1.47 (diluted EPS in Q2 2021) to $1.48 in Q4 2025.
  • Healthy Gross Margin: Gross profit margins have been robust, with gross profit steadily around half of revenue, reaching about $10.3 billion by Q4 2025 from about $9.2 billion in Q3 2021, reflecting effective cost controls.
  • Operating Income Increasing: Operating income showed growth from around $3.7 billion in Q3 2021 to $4.4 billion in later periods, peaking at $5.8 billion in early 2025, indicating operational efficiencies.
  • Strong Cash Flow: Net cash from operating activities remained strong, with $4.9 billion in Q1 2025 and $5.0 billion in Q2 2025 continuing through Q4 2025 with $4.99 billion, indicating consistent operational cash generation.
  • Effective Capital Allocation: The company continued to invest in property, plant, and equipment with CapEx roughly ranging between $700 million to just over $1 billion per quarter, supporting growth and maintenance. Share repurchases and dividend payments remain significant, showing commitment to shareholder returns.
  • Debt Management: Long-term debt fluctuated but remained in the $20-$25 billion range throughout the period. Repayment and issuance activities balanced to maintain total liabilities around $70 billion, reflecting stable capital structure management.
  • Dividend Growth: Dividends per common share increased gradually, reflecting confidence in sustainable earnings, with quarterly cash dividends rising from about $0.79 in early 2021 to over $1.00 by 2025.
  • Operating Expenses Variability: SG&A expenses showed some fluctuation, increasing to over $6.29 billion in Q4 2024 before easing back. Elevated expense levels in some quarters could affect operating margins if sustained.
  • Net Income Pressure in Certain Quarters: Net income dips were observed in quarters like Q4 2021 and some in 2023-to-2024 timeframe, linked to lower other income or higher operating expenses, which may signal challenges in certain periods.

Additional Observations:

  • Total assets and equity consistently increased, with total common equity around $45-$52 billion, supporting solid balance sheet strength.
  • Inventory and receivables levels rose in line with revenue growth, indicating growth in sales volume and asset utilization.

Conclusion:

Procter & Gamble has shown sustained growth in revenues, profits, and cash flow over the last four years, with effective deployment of capital towards dividends and share repurchases. The company maintains a stable financial position with manageable debt levels, and strong operational cash flows underpinning business operations. Some variability in expenses and net income on a quarter-to-quarter basis warrants monitoring, but overall, PG demonstrates a robust and mature financial profile attractive to investors seeking stable returns.

09/11/25 07:44 AM ETAI Generated. May Contain Errors.

Financials Breakdown Chart

Frequently Asked Questions About Procter & Gamble's Financials

When does Procter & Gamble's financial year end?

According to the most recent income statement we have on file, Procter & Gamble's fiscal year ends in June. Their fiscal year 2025 ended on June 30, 2025.

How has Procter & Gamble's net income changed over the last 10 years?

Procter & Gamble's net income appears to be on an upward trend, with a most recent value of $16.07 billion in 2025, rising from $7.14 billion in 2015. The previous period was $14.97 billion in 2024. Check out Procter & Gamble's forecast to explore projected trends and price targets.

What is Procter & Gamble's operating income?
Procter & Gamble's total operating income in 2025 was $20.45 billion, based on the following breakdown:
  • Total Gross Profit: $43.12 billion
  • Total Operating Expenses: $22.67 billion
How has Procter & Gamble's revenue changed over the last 10 years?

Over the last 10 years, Procter & Gamble's total revenue changed from $70.75 billion in 2015 to $84.28 billion in 2025, a change of 19.1%.

How much debt does Procter & Gamble have?

Procter & Gamble's total liabilities were at $72.95 billion at the end of 2025, a 1.6% increase from 2024, and a 9.8% increase since 2015.

How much cash does Procter & Gamble have?

In the past 10 years, Procter & Gamble's cash and equivalents has ranged from $0.00 in 2020 to $10.29 billion in 2021, and is currently $9.56 billion as of their latest financial filing in 2025.

How has Procter & Gamble's book value per share changed over the last 10 years?

Over the last 10 years, Procter & Gamble's book value per share changed from 22.61 in 2015 to 21.85 in 2025, a change of -3.4%.



This page (NYSE:PG) was last updated on 9/11/2025 by MarketBeat.com Staff
From Our Partners